Medline (MDLN) Invested Capital (2024 - 2026)

Medline (MDLN) has 3 years of Invested Capital data on file, last reported at $77.0 million in Q1 2026.

• On a quarterly basis, Invested Capital changed N/A year-over-year to $77.0 million in Q1 2026; TTM through Mar 2026 was $232.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $77.0 million, down 1.28% from the prior year.
• Invested Capital for Q1 2026 stood at $77.0 million, roughly flat from $77.0 million in the prior quarter.
• Over the last five years, Invested Capital for MDLN reached as high as $78.0 million in Q4 2024 and fell as low as $77.0 million in Q4 2025.
• Historically, Invested Capital has averaged $77.3 million across 3 years, with a median of $77.0 million in 2025.
• On a YoY basis, Invested Capital climbed as much as 1.28% in 2025 and fell as far as 1.28% in 2025.
• Year by year, Invested Capital stood at $78.0 million in 2024, then decreased by 1.28% to $77.0 million in 2025, then changed by 0.0% to $77.0 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $77.0 million in Q1 2026, $77.0 million in Q4 2025, and $78.0 million in Q4 2024.